RelB NF-κB Represses Estrogen Receptor α Expression via Induction of the Zinc Finger Protein Blimp1

REFERENCES

• Angelin-Duclos, C., K. Johnson, J. Liao, K. I. Lin, and K. Calame. 2002. An interfering form of Blimp-1 increases IgM secreting plasma cells and blocks maturation of peripheral B cells. Eur. J. Immunol. 32:3765–3775.
   PubMedGoogle Scholar
• Bild, A. H., G. Yao, J. T. Chang, Q. Wang, A. Potti, D. Chasse, M. B. Joshi, D. Harpole, J. M. Lancaster, A. Berchuck, J. A. Olson, Jr., J. R. Marks, H. K. Dressman, M. West, and J. R. Nevins. 2006. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353–357.
   PubMed Web of Science ®Google Scholar
• Blagosklonny, M. V., T. Schulte, P. Nguyen, J. Trepel, and L. M. Neckers. 1996. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1851–1854.
   PubMed Web of Science ®Google Scholar
• Bonizzi, G., M. Bebien, D. C. Otero, K. E. Johnson-Vroom, Y. Cao, D. Vu, A. G. Jegga, B. J. Aronow, G. Ghosh, R. C. Rickert, and M. Karin. 2004. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23:4202–4210.
   PubMed Web of Science ®Google Scholar
• Cadwallader, K. A., H. Paterson, S. G. Macdonald, and J. F. Hancock. 1994. N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Mol. Cell. Biol. 14:4722–4730.
   PubMedGoogle Scholar
• Calame, K. L., K. I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:205–230.
   PubMedGoogle Scholar
• Choi, J., K. Choi, E. N. Benveniste, S. B. Rho, Y. S. Hong, J. H. Lee, J. Kim, and K. Park. 2005. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res. 65:5554–5560.
   PubMed Web of Science ®Google Scholar
• Choy, E., V. K. Chiu, J. Silletti, M. Feoktistov, T. Morimoto, D. Michaelson, I. E. Ivanov, and M. R. Philips. 1999. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98:69–80.
   PubMed Web of Science ®Google Scholar
• Cogswell, P. C., D. C. Guttridge, W. K. Funkhouser, and A. S. Baldwin, Jr. 2000. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19:1123–1131.
   PubMed Web of Science ®Google Scholar
• Davis, M. M. 2007. Blimp-1 over Budapest. Nat. Immunol. 8:445–447.
   PubMedGoogle Scholar
• deConinck, E. C., L. A. McPherson, and R. J. Weigel. 1995. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. Cell. Biol. 15:2191–2196.
   PubMedGoogle Scholar
• deGraffenried, L. A., S. G. Hilsenbeck, and S. A. Fuqua. 2002. Sp1 is essential for estrogen receptor alpha gene transcription. J. Steroid Biochem. Mol. Biol. 82:7–18.
   PubMedGoogle Scholar
• deGraffenried, L. A., T. A. Hopp, A. J. Valente, R. A. Clark, and S. A. Fuqua. 2004. Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1, and ERα. Breast Cancer Res. Treat. 85:111–120.
   PubMed Web of Science ®Google Scholar
• Demicco, E. G., K. T. Kavanagh, R. Romieu-Mourez, X. Wang, S. R. Shin, E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein. 2005. RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted super-repressor IκB-alpha expression and promote carcinogenesis of the mammary gland. Mol. Cell. Biol. 25:10136–10147.
   PubMedGoogle Scholar
• Denis, G. V., Q. Yu, P. Ma, L. Deeds, D. V. Faller, and C. Y. Chen. 2003. Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J. Biol. Chem. 278:5775–5785.
   PubMedGoogle Scholar
• Fink, P. J. 2006. T cells join the Blimp-1 brigade. Nat. Immunol. 7:445–446.
   PubMedGoogle Scholar
• Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1–62.
   PubMed Web of Science ®Google Scholar
• Guo, S., and G. E. Sonenshein. 2004. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol. Cell. Biol. 24:8681–8690.
   PubMed Web of Science ®Google Scholar
• Gyory, I., J. Wu, G. Fejer, E. Seto, and K. L. Wright. 2004. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5:299–308.
   PubMedGoogle Scholar
• Jeay, S., S. Pianetti, H. M. Kagan, and G. E. Sonenshein. 2003. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-κB. Mol. Cell. Biol. 23:2251–2263.
   PubMed Web of Science ®Google Scholar
• Jiang, H. Y., C. Petrovas, and G. E. Sonenshein. 2002. RelB-p50 NF-κB complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-κB family members. J. Virol. 76:5737–5747.
   PubMedGoogle Scholar
• Johnson, K., M. Shapiro-Shelef, C. Tunyaplin, and K. Calame. 2005. Regulatory events in early and late B-cell differentiation. Mol. Immunol. 42:749–761.
   PubMedGoogle Scholar
• Kalaitzidis, D., and T. D. Gilmore. 2005. Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends Endocrinol. Metab. 16:46–52.
   PubMed Web of Science ®Google Scholar
• Keller, A. D., and T. Maniatis. 1991. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev. 5:868–879.
   PubMed Web of Science ®Google Scholar
• Lernbecher, T., U. Muller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767–770.
   PubMed Web of Science ®Google Scholar
• Lessard, L., L. R. Begin, M. E. Gleave, A. M. Mes-Masson, and F. Saad. 2005. Nuclear localization of nuclear factor-κB transcription factors in prostate cancer: an immunohistochemical study. Br. J. Cancer 93:1019–1023.
   PubMedGoogle Scholar
• Marienfeld, R., M. J. May, I. Berberich, E. Serfling, S. Ghosh, and M. Neumann. 2003. RelB forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278:19852–19860.
   PubMed Web of Science ®Google Scholar
• Martins, G. A., L. Cimmino, M. Shapiro-Shelef, M. Szabolcs, A. Herron, E. Magnusdottir, and K. Calame. 2006. Transcriptional repressor Blimp-1 regulates T-cell homeostasis and function. Nat. Immunol. 7:457–465.
   PubMed Web of Science ®Google Scholar
• Mineva, N. D., X. Wang, S. Yang, H. Ying, Z.-X. J. Xiao, M. F. Holick, and G. E. Sonenshein. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J. Cell Physiol., in press.
   Google Scholar
• Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, Jr., and G. W. Sledge, Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629–3639.
   PubMed Web of Science ®Google Scholar
• Navarro, P., A. M. Valverde, M. Benito, and M. Lorenzo. 1999. Activated Ha-ras induces apoptosis by association with phosphorylated Bcl-2 in a mitogen-activated protein kinase-independent manner. J. Biol. Chem. 274:18857–18863.
   PubMed Web of Science ®Google Scholar
• Oh, A. S., L. A. Lorant, J. N. Holloway, D. L. Miller, F. G. Kern, and D. El-Ashry. 2001. Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol. Endocrinol. 15:1344–1359.
   PubMed Web of Science ®Google Scholar
• Ohinata, Y., B. Payer, D. O'Carroll, K. Ancelin, Y. Ono, M. Sano, S. C. Barton, T. Obukhanych, M. Nussenzweig, A. Tarakhovsky, M. Saitou, and M. A. Surani. 2005. Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436:207–213.
   PubMed Web of Science ®Google Scholar
• Ohkubo, Y., M. Arima, E. Arguni, S. Okada, K. Yamashita, S. Asari, S. Obata, A. Sakamoto, M. Hatano, J. O.-Wang, M. Ebara, H. Saisho, and T. Tokuhisa. 2005. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J. Immunol. 174:7703–7710.
   PubMedGoogle Scholar
• Omidvar, N., S. Kogan, S. Beurlet, C. le Pogam, A. Janin, R. West, M. E. Noguera, M. Reboul, A. Soulie, C. Leboeuf, N. Setterblad, D. Felsher, E. Lagasse, A. Mohamedali, N. S. Thomas, P. Fenaux, M. Fontenay, M. Pla, G. J. Mufti, I. Weissman, C. Chomienne, and R. A. Padua. 2007. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res. 67:11657–11667.
   PubMedGoogle Scholar
• Puto, L. A., and J. C. Reed. 2008. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 22:998–1010.
   PubMedGoogle Scholar
• Rayet, B., and C. Gelinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938–6947.
   PubMed Web of Science ®Google Scholar
• Rebollo, A., D. Perez-Sala, and A. C. Martinez. 1999. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Oncogene 18:4930–4939.
   PubMed Web of Science ®Google Scholar
• Ren, B., K. J. Chee, T. H. Kim, and T. Maniatis. 1999. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13:125–137.
   PubMed Web of Science ®Google Scholar
• Romieu-Mourez, R., D. W. Kim, S. M. Shin, E. G. Demicco, E. Landesman-Bollag, D. C. Seldin, R. D. Cardiff, and G. E. Sonenshein. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23:5738–5754.
   PubMed Web of Science ®Google Scholar
• Schjerven, H., T. N. Tran, P. Brandtzaeg, and F. E. Johansen. 2004. De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor. J. Immunol. 173:1849–1857.
   PubMed Web of Science ®Google Scholar
• Sentman, C. L., J. R. Shutter, D. Hockenbery, O. Kanagawa, and S. J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879–888.
   PubMed Web of Science ®Google Scholar
• Sharma, D., J. Blum, X. Yang, N. Beaulieu, A. R. Macleod, and N. E. Davidson. 2005. Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol. Endocrinol. 19:1740–1751.
   PubMed Web of Science ®Google Scholar
• Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405–455.
   PubMedGoogle Scholar
• Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Investig. 100:2952–2960.
   PubMed Web of Science ®Google Scholar
• Stoffel, A., M. Chaurushiya, B. Singh, and A. J. Levine. 2004. Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis. Proc. Natl. Acad. Sci. USA 101:9079–9084.
   PubMedGoogle Scholar
• Suhasini, M., C. D. Reddy, E. P. Reddy, J. A. DiDonato, and R. B. Pilz. 1997. cAMP-induced NF-κB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene 15:1859–1870.
   PubMedGoogle Scholar
• Tanimoto, K., H. Eguchi, T. Yoshida, K. Hajiro-Nakanishi, and S. Hayashi. 1999. Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expression in human breast cancer. Nucleic Acids Res. 27:903–909.
   PubMedGoogle Scholar
• Tunyaplin, C., M. A. Shapiro, and K. L. Calame. 2000. Characterization of the B lymphocyte-induced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter. Nucleic Acids Res. 28:4846–4855.
   PubMedGoogle Scholar
• van de Vijver, M. J., Y. D. He, L. J. van't Veer, H. Dai, A. A. Hart, D. W. Voskuil, G. J. Schreiber, J. L. Peterse, C. Roberts, M. J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E. T. Rutgers, S. H. Friend, and R. Bernards. 2002. A gene expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347:1999–2009.
   PubMed Web of Science ®Google Scholar
• Van den Eynden, G. G., I. Van der Auwera, S. Van Laere, C. G. Colpaert, P. van Dam, S. Merajver, C. G. Kleer, A. L. Harris, E. A. Van Marck, L. Y. Dirix, and P. B. Vermeulen. 2004. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res. Treat. 85:13–22.
   PubMed Web of Science ®Google Scholar
• Van Laere, S. J., I. Van der Auwera, G. G. Van den Eynden, H. J. Elst, J. Weyler, A. L. Harris, P. van Dam, E. A. Van Marck, P. B. Vermeulen, and L. Y. Dirix. 2006. Nuclear factor-κB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-κB DNA-binding. Clin. Cancer Res. 12:3249–3256.
   PubMedGoogle Scholar
• Vilimas, T., J. Mascarenhas, T. Palomero, M. Mandal, S. Buonamici, F. Meng, B. Thompson, C. Spaulding, S. Macaroun, M. L. Alegre, B. L. Kee, A. Ferrando, L. Miele, and I. Aifantis. 2007. Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med. 13:70–77.
   PubMed Web of Science ®Google Scholar
• Vincent, S. D., N. R. Dunn, R. Sciammas, M. Shapiro-Shalef, M. M. Davis, K. Calame, E. K. Bikoff, and E. J. Robertson. 2005. The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development 132:1315–1325.
   PubMed Web of Science ®Google Scholar
• Wang, H. G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629–638.
   PubMed Web of Science ®Google Scholar
• Wang, X., K. Belguise, N. Kersual, K. H. Kirsch, N. D. Mineva, F. Galtier, D. Chalbos, and G. E. Sonenshein. 2007. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 9:470–478.
   PubMed Web of Science ®Google Scholar
• Wang, X., and G. E. Sonenshein. 2005. Induction of the RelB NF-κB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J. Virol. 79:95–105.
   PubMedGoogle Scholar
• Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331–340.
   PubMed Web of Science ®Google Scholar
• Xia, Y., S. Chen, Y. Wang, N. Mackman, G. Ku, D. Lo, and L. Feng. 1999. RelB modulation of IκBalpha stability as a mechanism of transcription suppression of interleukin-1α (IL-1α), IL-1β, and tumor necrosis factor alpha in fibroblasts. Mol. Cell. Biol. 19:7688–7696.
   PubMedGoogle Scholar
• Xu, Y., F. Fang, D. K. St Clair, S. Josson, P. Sompol, I. Spasojevic, and W. H. St. Clair. 2007. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1α,25-dihydroxyvitamin D3 in prostate cancer cells. Mol. Cancer Ther. 6:2048–2056.
   PubMedGoogle Scholar
• Yan, J., J. Jiang, C. A. Lim, Q. Wu, H. H. Ng, and K. C. Chin. 2007. BLIMP1 regulates cell growth through repression of p53 transcription. Proc. Natl. Acad. Sci. USA 104:1841–1846.
   PubMed Web of Science ®Google Scholar
• Yan, L., S. J. Nass, D. Smith, W. G. Nelson, J. G. Herman, and N. E. Davidson. 2003. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol. Ther. 2:552–556.
   PubMed Web of Science ®Google Scholar
• Yu, J., C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame. 2000. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20:2592–2603.
   PubMed Web of Science ®Google Scholar
• Zhu, W., A. Cowie, G. W. Wasfy, L. Z. Penn, B. Leber, and D. W. Andrews. 1996. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15:4130–4141.
   PubMed Web of Science ®Google Scholar